Track record · closed signal

CareTrust REIT, Inc. (CTRE) — closed signal from December 28, 2025

Target reached Published before the outcome was known, scored automatically when the window closed on March 28, 2026.

Predicted vs. what happened

CTRE price · publication thesis → realized outcomesplit-adjusted
$36.35 Published $39.62 Target $37.13 Window close $41.72 Peak
$34.86 – $36.33Entry zone — fair-value band
$36.35Published — price the day we called it
$39.62Target — the price the thesis aimed for
$41.72Peak — highest point inside the window, not a realized return
$37.13Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 46 days.

Peak price
$41.72
peak on February 27, 2026 — not a realized return
Peak gain
+14.8%
peak, from the publication price
Window close
$37.13
end-of-window price, context only
Days to target
46
Window
December 28, 2025 – March 28, 2026

The thesis — published December 28, 2025

Predicted growth
+10%
over the measurement window
Target price
$39.62
the price the thesis aimed for
Entry zone
$34.86 – $36.33
the fair-value band we waited for
Price at publication
$36.35
published December 28, 2025
Confidence
81%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

CTRE is a steadier real estate investment that still has room to rise. Analysts point to good sentiment, reliable business fundamentals, and a pause in price movement rather than a drop. The stock pays a roughly 3.7% dividend and models valuing it much higher suggest buyers may step in when it dips. Expect gradual gains over a few months, not a sudden surge.

Primary drivers

  • Pays a steady dividend that attracts income-focused buyers
  • Valuation models show it could be notably undervalued
  • Leases with healthcare operators make cash flows steadier
  • Recent sideways move gives clear levels to enter with limited risk

How it played out

CTRE: target reached in 46 days

Lyra published CTRE at 36.35 on 2025-12-28 with a short-term thesis for 10% expected growth. The thesis pointed to a steady dividend around 3.7%, valuation models that suggested the stock was undervalued, healthcare-operator leases, and a recent sideways move that gave entry levels.

Inside the window, CTRE reached the 39.62 target. It peaked at 41.72 on 2026-02-27, with a 14.8% peak gain, and reached the target in 46 days. By 2026-03-28, it ended at 37.13. The thesis played out, though the closing price was back below the peak.

What happened during the window

On 2026-02-06, Investor's Business Daily reported that CTRE's Relative Strength Rating rose to 83 and said the next report was expected around February 12.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All CTRE signals